Savara (SVRA) Research & Development (2010 - 2026)

Savara's (SVRA) quarterly Research & Development came in at $23.4 million in Q1 2026, up 22.13% year-on-year from $19.2 million in Q1 2025, and up 11.94% on a QoQ basis from $20.9 million in Q4 2025.

Savara (SVRA) Research & Development (2010 - 2026) Analysis & Trends

Savara (SVRA) has 17 years of Research & Development data on file, last reported at $23.4 million in Q1 2026.

  • On a quarterly basis, Research & Development rose 22.13% year-over-year to $23.4 million in Q1 2026; TTM through Mar 2026 was $85.6 million, a 6.55% increase from a year earlier, with the FY2025 full-year figure at $81.4 million, up 4.33% from the prior year.
  • Research & Development for Q1 2026 stood at $23.4 million, up from $20.9 million in the prior quarter.
  • Over the last five years, Research & Development for SVRA reached as high as $23.4 million in Q1 2026 and fell as low as $5.7 million in Q1 2022.
  • Historically, Research & Development has averaged $15.0 million across 5 years, with a median of $16.8 million in 2024.
  • Across the five-year window, Research & Development retreated 25.1% in 2022 and soared 97.7% in 2024, its largest moves.
  • Year by year, Research & Development stood at $7.6 million in 2022, then soared by 67.14% to $12.7 million in 2023, then jumped by 82.76% to $23.3 million in 2024, then retreated by 10.27% to $20.9 million in 2025, then rose by 11.94% to $23.4 million in 2026.
  • Per Business Quant data, the three most recent Research & Development figures were $23.4 million in Q1 2026, $20.9 million in Q4 2025, and $20.6 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -17.94 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 541.22 Mn
4 NuCana 279.75 Bn 279.75 Bn - -2.31 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 961.60 Mn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 1.54 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - 15.66 Mn
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 1.37 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 343.97 Mn
10 Savara 1.24 Bn 1.24 Bn - 23.40 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 23.40 Mn
Dec 31, 2025 20.90 Mn
Sep 30, 2025 20.59 Mn
Jun 30, 2025 20.75 Mn
Mar 31, 2025 19.16 Mn
Dec 31, 2024 23.29 Mn
Sep 30, 2024 20.31 Mn
Jun 30, 2024 17.62 Mn
Mar 31, 2024 16.81 Mn
Dec 31, 2023 12.75 Mn
Sep 30, 2023 13.87 Mn
Jun 30, 2023 8.91 Mn
Mar 31, 2023 8.74 Mn
Dec 31, 2022 7.63 Mn
Sep 30, 2022 8.15 Mn
Jun 30, 2022 6.42 Mn
Mar 31, 2022 5.68 Mn
Dec 31, 2021 7.62 Mn
Sep 30, 2021 6.53 Mn
Jun 30, 2021 7.25 Mn